scholarly journals Does time change the anxiety and depression scores for pregnant women on Covid‐19 pandemic?

2021 ◽  
Author(s):  
Ayşe Geren ◽  
Özer Birge ◽  
Mehmet Sait Bakır ◽  
Mehmet Sakıncı ◽  
Cem Yaşar Sanhal
Keyword(s):  
Pregnant Women ◽  
Time Change ◽  
Anxiety And Depression

scholarly journals Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control

2020 ◽  
Author(s):  
Björg Ásbjörnsdóttir ◽  
Marianne Vestgaard ◽  
Nicoline C. Do ◽  
Lene Ringholm ◽  
Lise L.T. Andersen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Pregnant Women ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
The Impact

scholarly journals Associations of COVID-19 related experiences with maternal anxiety and depression: implications for mental health management of pregnant women in the post-pandemic era

2021 ◽  
pp. 114115
Author(s):  
Wei Lin ◽  
Bo Wu ◽  
Bin Chen ◽  
Chuyan Zhong ◽  
Weikang Huang ◽  
...  
Keyword(s):  
Mental Health ◽  
Pregnant Women ◽  
Health Management ◽  
Maternal Anxiety ◽  
Anxiety And Depression

scholarly journals Mexican pregnant women show higher depression and anxiety with rising age and in the case of being single

2020 ◽  
Vol 26 (4) ◽  
pp. 227-236
Author(s):  
Irma Visoso Salgado ◽  
Jayson Leonel Moncada Mendoza ◽  
Hugo Mendieta Zerón
Keyword(s):  
Pregnant Women ◽  
Severe Depression ◽  
Cross Sectional Study ◽  
Anxiety And Depression ◽  
Depression And Anxiety ◽  
Mild Depression ◽  
Cross Sectional ◽  
Psychology Service ◽  
First Time ◽  
Severe Anxiety

Background. Pregnancy is an important predisposition period to develop anxiety and depression, with a direct impact on the woman’s offspring. The aim of this study was to report the correlation between depression and anxiety in pregnant women and its association with the marital status and age. Materials. A descriptive, retrospective and cross-sectional study was conducted in the outpatient care of the Psychology Service at the “Mónica Pretelini Sáenz” Maternal Perinatal Hospital (HMPMPS), Toluca, Mexico, from June 2012 to March 2019. As routine, the Beck Depression Inventory (BDI-II) and the Beck Anxiety Inventory-Trait (BAIT), were applied to all women seeking attention at the HMPMPS. Only pregnant patients were selected for this study, with the women referred for the first time to the external Psychology Clinic as inclusion criteria. Pearson’s correlation coefficient and the frequency of cases for age, BDI-II, and BAIT were obtained using the IBM SPSS Statistics ® v.23 software. Results. The study included 2947 pregnant patients with a mean age of 28.6 ± 6.9 years. Of these, 2616 (88.8%) presented with mild anxiety, 269 (9.1%) with moderate, and 62 (2.1%) with severe anxiety. On the other hand, 2149 (72.9%) patients presented with minimal depression, 341 (11.6%) mild depression, 268 (9.1%) moderate depression, and 189 (6.4%) had severe depression. The correlations between age and BDI-II was –0.026 (P = 0.152), between age and BAI was –0.038 (P = 0.037), and between BAIT and BDI-II 0.650 (P ≤ 0.001). Conclusions. The age group with the highest frequency of depression and anxiety was from 20 to 29 years. The absence of a stable partner represented an important risk factor for anxiety and depression during pregnancy.

Stress-protective effects of micronized progesterone in treatment of anxiety disorders in pregnant women after in vitro fertilisation

GYNECOLOGY ◽  
2021 ◽  
Vol 23 (4) ◽  
pp. 346-353
Author(s):  
Natalya I. Tapilskaya ◽  
Mikhail S. Nekrasov ◽  
Inna O. Krikheli ◽  
Ksenia V. Ob'edkova ◽  
Alexander M. Gzgzyan ◽  
...  
Keyword(s):  
Anxiety Disorders ◽  
Pregnant Women ◽  
Rating Scale ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
In Vitro Fertilisation ◽  
Group 3 ◽  
The Mean ◽  
Micronized Progesterone

Aim. To study a stress-protective efficacy of micronized progesterone (MP) in pregnant women with anxiety disorders after in vitro fertilisation (IVF). Materials and methods. We conducted a prospective, comparative open-label randomized trial in two IVF-clinics. A total of 98 pregnant women after IVF with anxiety disorders were recruited at the 9th week of pregnancy. Progesterone supplementation after IVF for luteal phase support was administered out until 9 weeks gestation. Then, after randomization, group 1 (n=35) received 400 mg per day of MP vaginally, group 2 (n=33) received 400 mg of MP orally, group 3 (n=30) was comparative for the other groups. The duration of progesterone treatment was 12 weeks. The Spielberger State Trait Anxiety Inventory (STAI), the Montgomerysberg depression rating scale (MADRS), Hospital Anxiety and Depression Scale (HADS), and the Epworth Sleepiness Questionnaires (ESQ) were used to compare maternal mood at 9 weeks (day of randomization) after delivery and at 283, 565, 847 days after randomization. Results. The mean STAI sumscore in MP-groups was significantly lower than in group 3 starting from day 565 and continued until the end of the study. There were no significant differences between vaginal and oral administration of progesterone. There were no significant differences between the mean sumscores when questioning on the HADS, MADRS and ESQ. Conclusion. Prolonged use of MP in pregnant women with anxiety disorders led to the prevention of manifestations of an increase in anxiety and depression. The stress-protective and neuromodulating properties of MP can determine additional indications for its prolonged administration in women with anxiety disorders and/or premorbid history.

scholarly journals The Psychometric Properties of the Patient Health Questionnaire-4 for Pregnant Women

2020 ◽  
Vol 17 (20) ◽  
pp. 7583
Author(s):  
María de la Fe Rodríguez-Muñoz ◽  
Natalia Ruiz-Segovia ◽  
Cristina Soto-Balbuena ◽  
Huynh-Nhu Le ◽  
María Eugenia Olivares-Crespo ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Antenatal Depression ◽  
Public Hospitals ◽  
Self Report ◽  
Patient Health Questionnaire ◽  
Anxiety And Depression ◽  
Depression And Anxiety ◽  
Health Questionnaire ◽  
Negative Consequences ◽  
Patient Health

Background: Perinatal anxiety and depression are common complications during pregnancy. The purpose of this study was to examine the item characteristics, reliability, validity, and factorial structure of the four-item Patient Health Questionnaire-4 (PHQ-4) and to determine the associations between scale scores and sociodemographic factors in a sample of pregnant women from Spain. Method: A total of 845 pregnant women were recruited from two public hospitals in Spain between 2014 and 2016. Participants completed a self-report questionnaire that included Patient Health Questionnaire-4, including the two-item Patient Health Questionnaire and the two-item Generalized Anxiety Disorder Screener. Results: Exploratory and confirmatory factor analysis and scale inter-correlations between the PHQ-4 and PHQ-9 revealed that the PHQ-4 has a bivariate structure and adequately assesses the dimensions of antenatal anxiety and depression. Conclusion: The PHQ-4 is a reliable and valid instrument to screen for depression and anxiety during pregnancy. The PHQ-4 is an ultra-brief measure that can be used to screen for antenatal depression and anxiety to prevent the negative consequences associated with these mental health conditions among mothers and infants.

The impact of resilience on prenatal anxiety and depression among pregnant women in Shanghai

2019 ◽  
Vol 250 ◽  
pp. 57-64 ◽  
Author(s):  
Xuemei Ma ◽  
Ying Wang ◽  
Hua Hu ◽  
Xuguang Grant Tao ◽  
Yunhui Zhang ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Anxiety And Depression ◽  
Prenatal Anxiety ◽  
The Impact

scholarly journals The COVID-19 Pandemic and Mental Well-Being of Pregnant Women in Japan: Need for Economic and Social Policy Interventions

2020 ◽  
pp. 1-6 ◽  
Author(s):  
Midori Matsushima ◽  
Hanna Horiguchi
Keyword(s):  
Social Support ◽  
Depressive Symptoms ◽  
Pregnant Women ◽  
Perceived Risk ◽  
Depression Scale ◽  
Well Being ◽  
Anxiety And Depression ◽  
Cutoff Score ◽  
Economic Wealth ◽  
Mental Well Being

ABSTRACT Objective: This study explores the mental well-being of pregnant women in Japan during the coronavirus disease (COVID-19) pandemic. Methods: We collected 1777 responses from pregnant women through an online survey. Using the Japanese version of the Edinburgh Postnatal Depression Scale (EPDS), we calculated the percentage of pregnant women above the cutoff (≥ 13), and the factor scores of anhedonia, anxiety, and depression. Regression analyses were performed to identify factors and socioeconomic characteristics correlated with depressive symptoms. Results: The point prevalence of pregnant women with an EPDS score of ≥ 13 was 17%. The mean scores were 0.73, 3.68, and 1.82 for anhedonia, anxiety, and depression, respectively. The probability of becoming above the cutoff score positively correlated with the cancellation of planned informal support, higher perceived risk for infection of COVID-19, difficulties in household finances, and lack of social support. Moreover, being younger, less wealthy, unemployed, and without a partner showed a significantly higher possibility of having a score above the cutoff. Conclusions: The present study found a high percentage of pregnant women with depressive symptoms. Notably, COVID-19-related variables, including perceived risk for the infection, fear of decreasing economic wealth, and social support, were significantly associated with depressive symptoms.

Is alexithymia a personality trait increasing the risk of depression? A prospective study evaluating alexithymia before, during and after a depressive episode

2008 ◽  
Vol 38 (12) ◽  
pp. 1717-1722 ◽  
Author(s):  
C. Marchesi ◽  
S. Bertoni ◽  
A. Cantoni ◽  
C. Maggini
Keyword(s):  
Prospective Study ◽  
Pregnant Women ◽  
Personality Trait ◽  
Depressive Episode ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
State Dependent ◽  
A Prospective Study ◽  
Care Evaluation

BackgroundWhether alexithymia is a personality trait that increases the risk of major depression (MD) is still debated. In this prospective study, alexithymic levels were evaluated before, during and after a depressive episode.MethodThe alexithymic levels, the presence of MD and the severity of anxious-depressive symptoms were evaluated at intervals of about 1 month in pregnant women attending the Centers for Prenatal Care, using the Toronto Alexithymia Scale (TAS), the Primary Care Evaluation of Mental Disorders (PRIME-MD) and the Hospital Anxiety and Depression Scale (HADS).ResultsSixteen women affected by MD, 21 affected by subthreshold depression and 112 non-depressed women were included in the study. Women who developed depression, compared to non-depressed women, showed similar TAS and HADS scores during the pre-morbid phase, a significant increase in the scores during depression and a significant decrease after remission, whereas no change was observed in non-depressed women.ConclusionsOur data suggest that in pregnant women alexithymia does not represent a personality trait that increases the risk of developing a depressive episode, and they support the hypothesis that alexithymia is a state-dependent phenomenon in depressed pregnant women.

Sign in / Sign up

Export Citation Format

Share Document